nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—ABCC1—Progesterone—uterine cancer	0.164	0.207	CbGbCtD
Atazanavir—ABCC1—Dactinomycin—uterine cancer	0.13	0.164	CbGbCtD
Atazanavir—ABCC1—Epirubicin—uterine cancer	0.0942	0.119	CbGbCtD
Atazanavir—ABCC1—Etoposide—uterine cancer	0.0734	0.0927	CbGbCtD
Atazanavir—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0615	0.0777	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—uterine cancer	0.05	0.0632	CbGbCtD
Atazanavir—CYP2C9—Progesterone—uterine cancer	0.0408	0.0515	CbGbCtD
Atazanavir—ABCB1—Progesterone—uterine cancer	0.0396	0.05	CbGbCtD
Atazanavir—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0358	0.0452	CbGbCtD
Atazanavir—ABCB1—Dactinomycin—uterine cancer	0.0314	0.0396	CbGbCtD
Atazanavir—CYP3A4—Progesterone—uterine cancer	0.0237	0.0299	CbGbCtD
Atazanavir—ABCB1—Etoposide—uterine cancer	0.0177	0.0224	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—uterine cancer	0.0121	0.0153	CbGbCtD
Atazanavir—CYP3A4—Etoposide—uterine cancer	0.0106	0.0134	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—uterine cancer	0.00723	0.00914	CbGbCtD
Atazanavir—Saquinavir—CYP11A1—uterine cancer	0.00305	1	CrCbGaD
Atazanavir—Increased appetite—Doxorubicin—uterine cancer	0.000205	0.001	CcSEcCtD
Atazanavir—Affect lability—Epirubicin—uterine cancer	0.000205	0.001	CcSEcCtD
Atazanavir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000204	0.000995	CcSEcCtD
Atazanavir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000204	0.000994	CcSEcCtD
Atazanavir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000203	0.000988	CcSEcCtD
Atazanavir—Malaise—Etoposide—uterine cancer	0.000202	0.000984	CcSEcCtD
Atazanavir—Dermatitis bullous—Doxorubicin—uterine cancer	0.000202	0.000983	CcSEcCtD
Atazanavir—Purpura—Doxorubicin—uterine cancer	0.0002	0.000975	CcSEcCtD
Atazanavir—Body temperature increased—Dactinomycin—uterine cancer	0.0002	0.000973	CcSEcCtD
Atazanavir—Abdominal pain—Dactinomycin—uterine cancer	0.0002	0.000973	CcSEcCtD
Atazanavir—Cardiac arrest—Epirubicin—uterine cancer	0.000198	0.000966	CcSEcCtD
Atazanavir—Hypoglycaemia—Doxorubicin—uterine cancer	0.000198	0.000963	CcSEcCtD
Atazanavir—Mood swings—Epirubicin—uterine cancer	0.000198	0.000962	CcSEcCtD
Atazanavir—Loss of consciousness—Etoposide—uterine cancer	0.000197	0.000959	CcSEcCtD
Atazanavir—Cough—Etoposide—uterine cancer	0.000195	0.000952	CcSEcCtD
Atazanavir—Convulsion—Etoposide—uterine cancer	0.000194	0.000945	CcSEcCtD
Atazanavir—Dehydration—Epirubicin—uterine cancer	0.000194	0.000945	CcSEcCtD
Atazanavir—Hypertension—Etoposide—uterine cancer	0.000193	0.000942	CcSEcCtD
Atazanavir—Pain in extremity—Doxorubicin—uterine cancer	0.000193	0.00094	CcSEcCtD
Atazanavir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000192	0.000937	CcSEcCtD
Atazanavir—Dry skin—Epirubicin—uterine cancer	0.000191	0.000931	CcSEcCtD
Atazanavir—Chest pain—Etoposide—uterine cancer	0.000191	0.000929	CcSEcCtD
Atazanavir—Affect lability—Doxorubicin—uterine cancer	0.00019	0.000925	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000189	0.000923	CcSEcCtD
Atazanavir—Discomfort—Etoposide—uterine cancer	0.000188	0.000918	CcSEcCtD
Atazanavir—Breast disorder—Epirubicin—uterine cancer	0.000188	0.000918	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000188	0.000915	CcSEcCtD
Atazanavir—Nasopharyngitis—Epirubicin—uterine cancer	0.000186	0.000908	CcSEcCtD
Atazanavir—Hypersensitivity—Dactinomycin—uterine cancer	0.000186	0.000907	CcSEcCtD
Atazanavir—Gastritis—Epirubicin—uterine cancer	0.000185	0.000899	CcSEcCtD
Atazanavir—Confusional state—Etoposide—uterine cancer	0.000184	0.000898	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000184	0.000896	CcSEcCtD
Atazanavir—Muscular weakness—Epirubicin—uterine cancer	0.000184	0.000896	CcSEcCtD
Atazanavir—Cardiac arrest—Doxorubicin—uterine cancer	0.000183	0.000894	CcSEcCtD
Atazanavir—Mood swings—Doxorubicin—uterine cancer	0.000183	0.00089	CcSEcCtD
Atazanavir—Infection—Etoposide—uterine cancer	0.000182	0.000885	CcSEcCtD
Atazanavir—Abdominal distension—Epirubicin—uterine cancer	0.000181	0.000884	CcSEcCtD
Atazanavir—Asthenia—Dactinomycin—uterine cancer	0.000181	0.000883	CcSEcCtD
Atazanavir—Dehydration—Doxorubicin—uterine cancer	0.000179	0.000874	CcSEcCtD
Atazanavir—Eosinophilia—Epirubicin—uterine cancer	0.000178	0.000869	CcSEcCtD
Atazanavir—Skin disorder—Etoposide—uterine cancer	0.000178	0.000865	CcSEcCtD
Atazanavir—Dry skin—Doxorubicin—uterine cancer	0.000177	0.000861	CcSEcCtD
Atazanavir—Hyperhidrosis—Etoposide—uterine cancer	0.000177	0.000861	CcSEcCtD
Atazanavir—Pancreatitis—Epirubicin—uterine cancer	0.000177	0.000861	CcSEcCtD
Atazanavir—Breast disorder—Doxorubicin—uterine cancer	0.000174	0.000849	CcSEcCtD
Atazanavir—Anorexia—Etoposide—uterine cancer	0.000174	0.000849	CcSEcCtD
Atazanavir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000174	0.000846	CcSEcCtD
Atazanavir—Diarrhoea—Dactinomycin—uterine cancer	0.000173	0.000842	CcSEcCtD
Atazanavir—Nasopharyngitis—Doxorubicin—uterine cancer	0.000173	0.00084	CcSEcCtD
Atazanavir—Gastritis—Doxorubicin—uterine cancer	0.000171	0.000832	CcSEcCtD
Atazanavir—Muscular weakness—Doxorubicin—uterine cancer	0.00017	0.000829	CcSEcCtD
Atazanavir—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00017	0.000829	CcSEcCtD
Atazanavir—Neutropenia—Epirubicin—uterine cancer	0.000168	0.000821	CcSEcCtD
Atazanavir—Abdominal distension—Doxorubicin—uterine cancer	0.000168	0.000818	CcSEcCtD
Atazanavir—Pollakiuria—Epirubicin—uterine cancer	0.000166	0.000811	CcSEcCtD
Atazanavir—Eosinophilia—Doxorubicin—uterine cancer	0.000165	0.000804	CcSEcCtD
Atazanavir—Photosensitivity reaction—Epirubicin—uterine cancer	0.000164	0.000801	CcSEcCtD
Atazanavir—Weight increased—Epirubicin—uterine cancer	0.000164	0.000799	CcSEcCtD
Atazanavir—Pancreatitis—Doxorubicin—uterine cancer	0.000163	0.000796	CcSEcCtD
Atazanavir—Weight decreased—Epirubicin—uterine cancer	0.000163	0.000794	CcSEcCtD
Atazanavir—Dyspnoea—Etoposide—uterine cancer	0.000163	0.000794	CcSEcCtD
Atazanavir—Hyperglycaemia—Epirubicin—uterine cancer	0.000163	0.000792	CcSEcCtD
Atazanavir—Somnolence—Etoposide—uterine cancer	0.000163	0.000792	CcSEcCtD
Atazanavir—Vomiting—Dactinomycin—uterine cancer	0.000161	0.000782	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000159	0.000776	CcSEcCtD
Atazanavir—Rash—Dactinomycin—uterine cancer	0.000159	0.000776	CcSEcCtD
Atazanavir—Decreased appetite—Etoposide—uterine cancer	0.000159	0.000774	CcSEcCtD
Atazanavir—Renal failure—Epirubicin—uterine cancer	0.000158	0.000769	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Etoposide—uterine cancer	0.000158	0.000769	CcSEcCtD
Atazanavir—Fatigue—Etoposide—uterine cancer	0.000158	0.000768	CcSEcCtD
Atazanavir—Neuropathy peripheral—Epirubicin—uterine cancer	0.000157	0.000767	CcSEcCtD
Atazanavir—Jaundice—Epirubicin—uterine cancer	0.000157	0.000763	CcSEcCtD
Atazanavir—Stomatitis—Epirubicin—uterine cancer	0.000157	0.000763	CcSEcCtD
Atazanavir—Pain—Etoposide—uterine cancer	0.000156	0.000762	CcSEcCtD
Atazanavir—Constipation—Etoposide—uterine cancer	0.000156	0.000762	CcSEcCtD
Atazanavir—Urinary tract infection—Epirubicin—uterine cancer	0.000156	0.000761	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—uterine cancer	0.000156	0.00076	CcSEcCtD
Atazanavir—Sweating—Epirubicin—uterine cancer	0.000154	0.00075	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—uterine cancer	0.000154	0.00075	CcSEcCtD
Atazanavir—Haematuria—Epirubicin—uterine cancer	0.000153	0.000746	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000152	0.000741	CcSEcCtD
Atazanavir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000152	0.00074	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—uterine cancer	0.000152	0.000739	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—uterine cancer	0.000151	0.000735	CcSEcCtD
Atazanavir—Feeling abnormal—Etoposide—uterine cancer	0.000151	0.000734	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—uterine cancer	0.00015	0.000733	CcSEcCtD
Atazanavir—Nausea—Dactinomycin—uterine cancer	0.00015	0.000731	CcSEcCtD
Atazanavir—Gastrointestinal pain—Etoposide—uterine cancer	0.000149	0.000728	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000147	0.000718	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—uterine cancer	0.000146	0.000712	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000146	0.00071	CcSEcCtD
Atazanavir—Urticaria—Etoposide—uterine cancer	0.000145	0.000708	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—uterine cancer	0.000145	0.000706	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—uterine cancer	0.000145	0.000706	CcSEcCtD
Atazanavir—Abdominal pain—Etoposide—uterine cancer	0.000145	0.000704	CcSEcCtD
Atazanavir—Body temperature increased—Etoposide—uterine cancer	0.000145	0.000704	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—uterine cancer	0.000144	0.000704	CcSEcCtD
Atazanavir—Hepatitis—Epirubicin—uterine cancer	0.000144	0.000703	CcSEcCtD
Atazanavir—Hypoaesthesia—Epirubicin—uterine cancer	0.000144	0.000699	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—uterine cancer	0.000143	0.000694	CcSEcCtD
Atazanavir—Urinary tract disorder—Epirubicin—uterine cancer	0.000142	0.000694	CcSEcCtD
Atazanavir—Oedema peripheral—Epirubicin—uterine cancer	0.000142	0.000692	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—uterine cancer	0.000142	0.000691	CcSEcCtD
Atazanavir—Connective tissue disorder—Epirubicin—uterine cancer	0.000142	0.000691	CcSEcCtD
Atazanavir—Urethral disorder—Epirubicin—uterine cancer	0.000141	0.000689	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000141	0.000685	CcSEcCtD
Atazanavir—Erythema multiforme—Epirubicin—uterine cancer	0.000136	0.000664	CcSEcCtD
Atazanavir—Eye disorder—Epirubicin—uterine cancer	0.000135	0.000657	CcSEcCtD
Atazanavir—Hypersensitivity—Etoposide—uterine cancer	0.000135	0.000656	CcSEcCtD
Atazanavir—Tinnitus—Epirubicin—uterine cancer	0.000134	0.000655	CcSEcCtD
Atazanavir—Cardiac disorder—Epirubicin—uterine cancer	0.000134	0.000652	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—uterine cancer	0.000133	0.00065	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—uterine cancer	0.000133	0.000647	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000132	0.000642	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—uterine cancer	0.000131	0.00064	CcSEcCtD
Atazanavir—Asthenia—Etoposide—uterine cancer	0.000131	0.000639	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000131	0.000639	CcSEcCtD
Atazanavir—Angiopathy—Epirubicin—uterine cancer	0.000131	0.000638	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—uterine cancer	0.000131	0.000637	CcSEcCtD
Atazanavir—Immune system disorder—Epirubicin—uterine cancer	0.00013	0.000635	CcSEcCtD
Atazanavir—Mediastinal disorder—Epirubicin—uterine cancer	0.00013	0.000633	CcSEcCtD
Atazanavir—Pruritus—Etoposide—uterine cancer	0.000129	0.00063	CcSEcCtD
Atazanavir—Alopecia—Epirubicin—uterine cancer	0.000127	0.000621	CcSEcCtD
Atazanavir—Mental disorder—Epirubicin—uterine cancer	0.000126	0.000616	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—uterine cancer	0.000126	0.000615	CcSEcCtD
Atazanavir—Malnutrition—Epirubicin—uterine cancer	0.000126	0.000612	CcSEcCtD
Atazanavir—Diarrhoea—Etoposide—uterine cancer	0.000125	0.000609	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—uterine cancer	0.000125	0.000608	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—uterine cancer	0.000124	0.000606	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—uterine cancer	0.000124	0.000603	CcSEcCtD
Atazanavir—Flatulence—Epirubicin—uterine cancer	0.000124	0.000603	CcSEcCtD
Atazanavir—Tension—Epirubicin—uterine cancer	0.000123	0.0006	CcSEcCtD
Atazanavir—Dysgeusia—Epirubicin—uterine cancer	0.000123	0.000599	CcSEcCtD
Atazanavir—Nervousness—Epirubicin—uterine cancer	0.000122	0.000594	CcSEcCtD
Atazanavir—Back pain—Epirubicin—uterine cancer	0.000121	0.000592	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—uterine cancer	0.000121	0.00059	CcSEcCtD
Atazanavir—Dizziness—Etoposide—uterine cancer	0.000121	0.000589	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—uterine cancer	0.000121	0.000587	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—uterine cancer	0.00012	0.000586	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—uterine cancer	0.000118	0.000575	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—uterine cancer	0.000117	0.00057	CcSEcCtD
Atazanavir—Ill-defined disorder—Epirubicin—uterine cancer	0.000116	0.000568	CcSEcCtD
Atazanavir—Vomiting—Etoposide—uterine cancer	0.000116	0.000566	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—uterine cancer	0.000116	0.000566	CcSEcCtD
Atazanavir—Agitation—Epirubicin—uterine cancer	0.000115	0.000562	CcSEcCtD
Atazanavir—Rash—Etoposide—uterine cancer	0.000115	0.000562	CcSEcCtD
Atazanavir—Dermatitis—Etoposide—uterine cancer	0.000115	0.000561	CcSEcCtD
Atazanavir—Headache—Etoposide—uterine cancer	0.000115	0.000558	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—uterine cancer	0.000114	0.000558	CcSEcCtD
Atazanavir—Tension—Doxorubicin—uterine cancer	0.000114	0.000555	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—uterine cancer	0.000114	0.000554	CcSEcCtD
Atazanavir—Malaise—Epirubicin—uterine cancer	0.000113	0.000552	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—uterine cancer	0.000113	0.00055	CcSEcCtD
Atazanavir—Syncope—Epirubicin—uterine cancer	0.000113	0.000549	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—uterine cancer	0.000112	0.000547	CcSEcCtD
Atazanavir—Palpitations—Epirubicin—uterine cancer	0.000111	0.000541	CcSEcCtD
Atazanavir—Loss of consciousness—Epirubicin—uterine cancer	0.00011	0.000538	CcSEcCtD
Atazanavir—Cough—Epirubicin—uterine cancer	0.00011	0.000534	CcSEcCtD
Atazanavir—Convulsion—Epirubicin—uterine cancer	0.000109	0.00053	CcSEcCtD
Atazanavir—Nausea—Etoposide—uterine cancer	0.000109	0.000529	CcSEcCtD
Atazanavir—Hypertension—Epirubicin—uterine cancer	0.000108	0.000528	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000108	0.000525	CcSEcCtD
Atazanavir—Chest pain—Epirubicin—uterine cancer	0.000107	0.000521	CcSEcCtD
Atazanavir—Arthralgia—Epirubicin—uterine cancer	0.000107	0.000521	CcSEcCtD
Atazanavir—Myalgia—Epirubicin—uterine cancer	0.000107	0.000521	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—uterine cancer	0.000107	0.00052	CcSEcCtD
Atazanavir—Anxiety—Epirubicin—uterine cancer	0.000107	0.000519	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000106	0.000517	CcSEcCtD
Atazanavir—Discomfort—Epirubicin—uterine cancer	0.000106	0.000515	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—uterine cancer	0.000105	0.00051	CcSEcCtD
Atazanavir—Dry mouth—Epirubicin—uterine cancer	0.000105	0.000509	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—uterine cancer	0.000104	0.000508	CcSEcCtD
Atazanavir—Confusional state—Epirubicin—uterine cancer	0.000103	0.000503	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—uterine cancer	0.000103	0.0005	CcSEcCtD
Atazanavir—Oedema—Epirubicin—uterine cancer	0.000102	0.000499	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—uterine cancer	0.000102	0.000497	CcSEcCtD
Atazanavir—Infection—Epirubicin—uterine cancer	0.000102	0.000496	CcSEcCtD
Atazanavir—Cough—Doxorubicin—uterine cancer	0.000101	0.000494	CcSEcCtD
Atazanavir—Shock—Epirubicin—uterine cancer	0.000101	0.000491	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—uterine cancer	0.000101	0.00049	CcSEcCtD
Atazanavir—Nervous system disorder—Epirubicin—uterine cancer	0.0001	0.00049	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—uterine cancer	0.0001	0.000489	CcSEcCtD
Atazanavir—Skin disorder—Epirubicin—uterine cancer	9.95e-05	0.000485	CcSEcCtD
Atazanavir—Hyperhidrosis—Epirubicin—uterine cancer	9.91e-05	0.000483	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—uterine cancer	9.89e-05	0.000482	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—uterine cancer	9.89e-05	0.000482	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—uterine cancer	9.89e-05	0.000482	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—uterine cancer	9.86e-05	0.00048	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	9.82e-05	0.000479	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—uterine cancer	9.77e-05	0.000476	CcSEcCtD
Atazanavir—Anorexia—Epirubicin—uterine cancer	9.77e-05	0.000476	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—uterine cancer	9.67e-05	0.000471	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—uterine cancer	9.56e-05	0.000466	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—uterine cancer	9.48e-05	0.000462	CcSEcCtD
Atazanavir—Infection—Doxorubicin—uterine cancer	9.42e-05	0.000459	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.34e-05	0.000455	CcSEcCtD
Atazanavir—Shock—Doxorubicin—uterine cancer	9.33e-05	0.000454	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—uterine cancer	9.3e-05	0.000453	CcSEcCtD
Atazanavir—Insomnia—Epirubicin—uterine cancer	9.27e-05	0.000452	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—uterine cancer	9.21e-05	0.000449	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—uterine cancer	9.17e-05	0.000447	CcSEcCtD
Atazanavir—Dyspnoea—Epirubicin—uterine cancer	9.14e-05	0.000445	CcSEcCtD
Atazanavir—Somnolence—Epirubicin—uterine cancer	9.11e-05	0.000444	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—uterine cancer	9.04e-05	0.00044	CcSEcCtD
Atazanavir—Dyspepsia—Epirubicin—uterine cancer	9.02e-05	0.000439	CcSEcCtD
Atazanavir—Decreased appetite—Epirubicin—uterine cancer	8.91e-05	0.000434	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Epirubicin—uterine cancer	8.85e-05	0.000431	CcSEcCtD
Atazanavir—Fatigue—Epirubicin—uterine cancer	8.83e-05	0.00043	CcSEcCtD
Atazanavir—Pain—Epirubicin—uterine cancer	8.76e-05	0.000427	CcSEcCtD
Atazanavir—Constipation—Epirubicin—uterine cancer	8.76e-05	0.000427	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.64e-05	0.000421	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—uterine cancer	8.58e-05	0.000418	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—uterine cancer	8.45e-05	0.000412	CcSEcCtD
Atazanavir—Feeling abnormal—Epirubicin—uterine cancer	8.44e-05	0.000411	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—uterine cancer	8.43e-05	0.000411	CcSEcCtD
Atazanavir—Gastrointestinal pain—Epirubicin—uterine cancer	8.38e-05	0.000408	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—uterine cancer	8.35e-05	0.000407	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—uterine cancer	8.24e-05	0.000402	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—uterine cancer	8.19e-05	0.000399	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—uterine cancer	8.17e-05	0.000398	CcSEcCtD
Atazanavir—Urticaria—Epirubicin—uterine cancer	8.14e-05	0.000397	CcSEcCtD
Atazanavir—Pain—Doxorubicin—uterine cancer	8.11e-05	0.000395	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—uterine cancer	8.11e-05	0.000395	CcSEcCtD
Atazanavir—Abdominal pain—Epirubicin—uterine cancer	8.1e-05	0.000395	CcSEcCtD
Atazanavir—Body temperature increased—Epirubicin—uterine cancer	8.1e-05	0.000395	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—uterine cancer	7.81e-05	0.000381	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—uterine cancer	7.75e-05	0.000378	CcSEcCtD
Atazanavir—Hypersensitivity—Epirubicin—uterine cancer	7.55e-05	0.000368	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—uterine cancer	7.53e-05	0.000367	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—uterine cancer	7.5e-05	0.000365	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—uterine cancer	7.5e-05	0.000365	CcSEcCtD
Atazanavir—Asthenia—Epirubicin—uterine cancer	7.35e-05	0.000358	CcSEcCtD
Atazanavir—Pruritus—Epirubicin—uterine cancer	7.25e-05	0.000353	CcSEcCtD
Atazanavir—Diarrhoea—Epirubicin—uterine cancer	7.01e-05	0.000342	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—uterine cancer	6.99e-05	0.00034	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—uterine cancer	6.8e-05	0.000331	CcSEcCtD
Atazanavir—Dizziness—Epirubicin—uterine cancer	6.78e-05	0.00033	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—uterine cancer	6.71e-05	0.000327	CcSEcCtD
Atazanavir—Vomiting—Epirubicin—uterine cancer	6.52e-05	0.000317	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—uterine cancer	6.49e-05	0.000316	CcSEcCtD
Atazanavir—Rash—Epirubicin—uterine cancer	6.46e-05	0.000315	CcSEcCtD
Atazanavir—Dermatitis—Epirubicin—uterine cancer	6.45e-05	0.000314	CcSEcCtD
Atazanavir—Headache—Epirubicin—uterine cancer	6.42e-05	0.000313	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—uterine cancer	6.27e-05	0.000305	CcSEcCtD
Atazanavir—Nausea—Epirubicin—uterine cancer	6.09e-05	0.000297	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—uterine cancer	6.03e-05	0.000294	CcSEcCtD
Atazanavir—Rash—Doxorubicin—uterine cancer	5.98e-05	0.000291	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—uterine cancer	5.97e-05	0.000291	CcSEcCtD
Atazanavir—Headache—Doxorubicin—uterine cancer	5.94e-05	0.000289	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—uterine cancer	5.63e-05	0.000274	CcSEcCtD
